Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Clinical trial NCT06307249 · RECRUITING

Trial details

NCT number: NCT06307249
Sponsor: Lebanese University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Colorectal Cancer Breast Cancer Ovarian Cancer Lung Cancer Targeted Therapy Chemotherapy Immunotherapy Precision Therapy

Start date: 2023-02-15
Primary completion: 2025-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.